You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Arthrogryposis

Showing 1 - 25 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Arthrogryposis Multiplex Congenita (AMC) Trial (ultrasound muscle imaging technique)

Not yet recruiting
  • Arthrogryposis Multiplex Congenita (AMC)
  • ultrasound muscle imaging technique
  • (no location specified)
Nov 9, 2023

Pediatric and Adult Registry for Patients With ARThrogryposis

Recruiting
  • Arthrogryposis Multiplex Congenita (AMC)
    • La Tronche, France
      CHU Grenoble Alpes
    Jan 3, 2023

    Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation

    Completed
    • Arthrogryposis Multiplex Congenita
    • +2 more
    • No intervention
    • La Tronche, France
      CHU Grenoble Alpes
    Jan 3, 2023

    Treatment Outcomes in Freeman-Sheldon Syndrome

    Terminated
    • Freeman-Sheldon Syndrome
    • +15 more
    • PTSD Checklist-Civilian (PCL-C)
    • +6 more
    • Buckhannon, West Virginia
      Freeman-Sheldon Research Group, Inc. Headquarters
    Jun 15, 2022

    Treatment Outcomes in Freeman-Sheldon Syndrome

    Recruiting
    • Freeman-Burian Syndrome
    • +7 more
    • Guided Health History for Freeman-Burian Syndrome Questionnaire
    • +9 more
    • Fairfax, Virginia
      Office of Craig R Dufresne, MD, PC
    Jul 15, 2022

    ArthrogypOsis,Congenital Neuromuscular Disease

    Completed
    • Diagnosis of Arthrogryposis Amyoplasia or Distal Arthrogryposis
    • +2 more
    • no intervention
    • La Tronche, France
      Chu Grenoble Alpes
    Nov 16, 2021

    Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

    Not yet recruiting
    • Autosomal Dominant Optic Atrophy
    • +3 more
      • Sydney, Australia
        Sydney Eye Hospital
      Nov 15, 2023

      Neurologic Diseases, Hemiparesis, Quadriplegia Trial in Wilmington, Philadelphia (Neurosleeve)

      Recruiting
      • Neurologic Diseases
      • +13 more
      • Neurosleeve
      • Wilmington, Delaware
      • +1 more
      Dec 2, 2022

      Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Diseases Trial in New Taipei City, Taipei (Atorvastatin 20 Mg Oral

      Enrolling by invitation
      • Autosomal Dominant Polycystic Kidney Disease
      • Chronic Kidney Diseases
      • Atorvastatin 20 Mg Oral Tablet
      • Sodium Bicarbonate 600 Mg Oral Tablet
      • New Taipei City, Taiwan
      • +2 more
      May 19, 2023

      Uncontrolled Hypertension, Autosomal Dominant Polycystic Kidney Disease, Renal Denervation Trial in Erlangen (Renal denervation)

      Recruiting
      • Uncontrolled Hypertension
      • +2 more
      • Renal denervation
      • Erlangen, Germany
        University Hospital FAU Erlangen-Nürnberg
      Jul 11, 2022

      Polycystic Kidney, Autosomal Dominant Trial in Aurora (Empagliflozin, Placebo)

      Not yet recruiting
      • Polycystic Kidney, Autosomal Dominant
      • Aurora, Colorado
        University of Coloardo Anschutz Medical Campus
      Aug 18, 2022

      Autosomal Dominant Hypocalcemia (ADH) Trial in Greenville (Encaleret, Calcium supplements and active Vitamin D (calcitriol,

      Recruiting
      • Autosomal Dominant Hypocalcemia (ADH)
      • Encaleret
      • Calcium supplements and active Vitamin D (calcitriol, alfacalcidol, falecalcitriol, etc.)
      • Greenville, North Carolina
        Physicians East
      Jan 9, 2023

      Liver Cyst, Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney Trial (aspiration sclerotherapy versus laparoscopic

      Not yet recruiting
      • Liver Cyst
      • +3 more
      • aspiration sclerotherapy versus laparoscopic fenestration
      • (no location specified)
      Aug 11, 2022

      Autosomal Dominant Polycystic Kidney Disease (ADPKD)

      Recruiting
      • Autosomal Dominant Polycystic Kidney Disease
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Aug 15, 2022

        Polycystic Kidney, Autosomal Dominant Trial in Aurora (Dietary)

        Active, not recruiting
        • Polycystic Kidney, Autosomal Dominant
        • Dietary
        • Aurora, Colorado
          University of Colorado - Anschutz Medical Campus
        May 16, 2022

        Autosomal Dominant Polycystic Kidney, Hypertension, Endothelial Dysfunction Trial in Sydney, Westmead (Beetroot juice,

        Recruiting
        • Autosomal Dominant Polycystic Kidney
        • +2 more
        • Beetroot juice
        • Nitrate-depleted beetroot juice
        • Sydney, New South Wales, Australia
        • +1 more
        Jan 31, 2023

        Autosomal Dominant Hypocalcemia (ADH) Trial run by the (CLTX-305)

        Active, not recruiting
        • Autosomal Dominant Hypocalcemia (ADH)
        • Bethesda, Maryland
          National Institute of Health
        Jul 20, 2022

        A Prospective Observational Study of Foam Sclerotherapy .

        Recruiting
        • Autosomal Dominant Polycystic Kidney
        • +3 more
          • Rochester, Minnesota
            Mayo Clinic
          Jul 11, 2022

          Autosomal Dominant Polycystic Kidney Disease Trial in Los Angeles (Pravastatin, sodium citrate)

          Enrolling by invitation
          • Autosomal Dominant Polycystic Kidney Disease
          • Los Angeles, California
            Keck School of Medicine of University of Southern California
          Jan 24, 2022

          Cerebral Palsy, Myelomeningocele, Arthrogryposis Trial in Chicago Heights (adapted Chicago Run running program)

          Enrolling by invitation
          • Cerebral Palsy
          • +4 more
          • adapted Chicago Run running program
          • Chicago Heights, Illinois
            Northwestern University
          Jun 28, 2021

          Polycystic Kidney, Autosomal Dominant Trial in Aurora (Weight Loss)

          Completed
          Has Results
          • Polycystic Kidney, Autosomal Dominant
          • Weight Loss
          • Aurora, Colorado
            Kristen Nowak
          Feb 8, 2022

          Autosomal Dominant Polycystic Kidney Trial in Melbourne (AL01211 or Placebo (Part A), AL01211 or Placebo (Part B))

          Active, not recruiting
          • Autosomal Dominant Polycystic Kidney
          • AL01211 or Placebo (Part A)
          • AL01211 or Placebo (Part B)
          • Melbourne, Victoria, Australia
            Nucleus Network
          May 16, 2022

          Autosomal Dominant Polycystic Kidney Disease Trial in New York

          Active, not recruiting
          • Autosomal Dominant Polycystic Kidney Disease
            • New York, New York
              Weill Cornell Medicine
            Jul 29, 2021

            Polycystic Kidney, Autosomal Dominant Trial in United States (KD019 (tesevatinib))

            Completed
            Has Results
            • Polycystic Kidney, Autosomal Dominant
            • Los Angeles, California
            • +10 more
            Oct 12, 2022

            Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2 Trial in Moscow (genetic,

            Recruiting
            • Hypercholesterolemia, Familial
            • +25 more
            • Genetic Testing
            • +7 more
            • Moscow, Russian Federation
              National Medical Research Centre for Therapy and Preventive Medi
            Jul 25, 2022